IceCure Medical (ICCM) Expected to Announce Quarterly Earnings on Thursday

IceCure Medical (NASDAQ:ICCM) is expected to be releasing its earnings data before the market opens on Thursday, March 27th. Analysts expect IceCure Medical to post earnings of ($0.07) per share and revenue of $1.07 million for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

IceCure Medical Stock Performance

IceCure Medical stock opened at $1.18 on Wednesday. IceCure Medical has a 52 week low of $0.48 and a 52 week high of $1.66. The company has a current ratio of 2.67, a quick ratio of 2.27 and a debt-to-equity ratio of 0.02. The stock has a market cap of $65.49 million, a P/E ratio of -4.07 and a beta of 0.37. The stock has a 50 day moving average of $1.32 and a 200-day moving average of $0.98.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and set a $2.50 price objective on shares of IceCure Medical in a report on Wednesday, November 27th.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.